New therapies and combination regimens may allow a more tailored approach.
Chelsey Lindner, PharmD, BCOP
Advertisement
Articles by Chelsey Lindner, PharmD, BCOP
It is important to promote the ongoing development of best practices for integrated specialty pharmacies in academic health systems.
Advertisement
Latest Updated Articles
Assessing the Landscape of HER2+ Breast Cancer TreatmentApril 18th 2022
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Scrutiny of GLP-1 Compounding Is Just Getting Started, Expert Says
2
The Biosimilar Conversation Nobody Is Having at the Pharmacy Counter: Why Adoption Is Still Struggling and What We Can Do About It
3
FDA Accepts NDA for Giredestrant in Early-Stage ER-Positive Breast Cancer Under Priority Review
4
From Misnomer to Meaning: A Patient-Centered Shift from PCOS to PMOS
5